
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Ashland Global Holdings Inc (ASH)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: ASH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $65.11
1 Year Target Price $65.11
6 | Strong Buy |
1 | Buy |
4 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -17.07% | Avg. Invested days 30 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.59B USD | Price to earnings Ratio - | 1Y Target Price 65.11 |
Price to earnings Ratio - | 1Y Target Price 65.11 | ||
Volume (30-day avg) 11 | Beta 0.48 | 52 Weeks Range 44.51 - 87.09 | Updated Date 08/28/2025 |
52 Weeks Range 44.51 - 87.09 | Updated Date 08/28/2025 | ||
Dividends yield (FY) 2.88% | Basic EPS (TTM) -17.97 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -46.07% | Operating Margin (TTM) 7.34% |
Management Effectiveness
Return on Assets (TTM) 1.78% | Return on Equity (TTM) -34.43% |
Valuation
Trailing PE - | Forward PE 12.17 | Enterprise Value 3864957222 | Price to Sales(TTM) 1.38 |
Enterprise Value 3864957222 | Price to Sales(TTM) 1.38 | ||
Enterprise Value to Revenue 2.07 | Enterprise Value to EBITDA 53.88 | Shares Outstanding 45706000 | Shares Floating 41773417 |
Shares Outstanding 45706000 | Shares Floating 41773417 | ||
Percent Insiders 1.08 | Percent Institutions 98.16 |
Upturn AI SWOT
Ashland Global Holdings Inc

Company Overview
History and Background
Ashland Global Holdings Inc. was founded in 1924 as Ashland Refining Company. It evolved from a petroleum refiner to a specialty materials company, undergoing significant restructuring and divestitures over the years.
Core Business Areas
- Life Sciences: Provides specialty ingredients and solutions for the pharmaceutical, nutraceutical, and personal care markets. Includes products like film formers, rheology modifiers, and delivery systems.
- Specialty Additives: Offers a range of additives and functional ingredients for coatings, adhesives, construction, energy, and other industrial applications.
- Intermediates: Produces chemicals for use in a variety of industries.
Leadership and Structure
The company is led by Guillermo Novo (Chairman & CEO) and has a typical corporate structure with a board of directors and various executive leadership roles overseeing different business segments and functions.
Top Products and Market Share
Key Offerings
- Benecelu2122: Methylcellulose polymers used in pharmaceutical and food applications; competitors include Dow and Shin-Etsu.
- Aquaflowu2122: Rheology modifiers for waterborne coatings; competes with Elementis Specialties and BYK Additives & Instruments.
- Viatelu2122: Bio-based polymers for various applications; competitors include DuPont and BASF.
Market Dynamics
Industry Overview
The specialty chemicals industry is characterized by innovation, regulatory compliance, and customer-specific solutions. Growth is driven by demand from various end markets such as pharmaceuticals, coatings, and personal care.
Positioning
Ashland holds a strong position in several niche markets, leveraging its technical expertise and application knowledge to provide differentiated products and services. Its competitive advantage lies in its focus on specialty ingredients and solutions.
Total Addressable Market (TAM)
The TAM for specialty chemicals is estimated to be in the hundreds of billions of dollars globally. Ashland is positioned to capture a portion of this market through its targeted approach and strong customer relationships.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Technical expertise
- Customer-centric approach
- Diverse product portfolio
- Global presence
Weaknesses
- Exposure to cyclical industries
- Dependence on key suppliers
- Price volatility of raw materials
- Integration challenges from acquisitions
- Potential environmental liabilities
Opportunities
- Expanding into emerging markets
- Developing new applications for existing products
- Acquiring complementary businesses
- Leveraging digital technologies
- Focusing on sustainable solutions
Threats
- Economic downturns
- Intense competition
- Changing regulations
- Technological disruptions
- Fluctuations in currency exchange rates
Competitors and Market Share
Key Competitors
- DD
- BASF
- EMN
Competitive Landscape
Ashland's advantages include its specialty focus and strong customer relationships. Disadvantages include exposure to cyclical industries and dependence on key suppliers. Compared to competitors like Dow and BASF, Ashland is more specialized.
Major Acquisitions
Pharmachem
- Year: 2017
- Acquisition Price (USD millions): 660
- Strategic Rationale: Expanded Ashland's presence in the nutraceuticals market.
Growth Trajectory and Initiatives
Historical Growth: Details on how the company grew in past years and the metrics used to show it, such as revenue and profit margin.
Future Projections: Based on Analyst estimates, we can detail what will drive growth for the company.
Recent Initiatives: Details on what the company did recently, such as expanding into different markets or R&D projects.
Summary
Ashland is a specialty materials company with a strong position in niche markets and customer centric solutions. Its diverse product portfolio has resulted in consistent growth, but it faces risks from the cyclical industries, price volatility of raw materials, and intense competition. Ashland should capitalize on opportunities in emerging markets and developing new applications for its products. The company has a well established track record of success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ashland Global Holdings Inc
Exchange NYSE | Headquaters Wilmington, DE, United States | ||
IPO Launch date 1983-04-06 | Chairman & CEO Mr. Guillermo Novo | ||
Sector Basic Materials | Industry Specialty Chemicals | Full time employees 2960 | Website https://www.ashland.com |
Full time employees 2960 | Website https://www.ashland.com |
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.